Thirty day outcomes of Indian patients in a multicenteric hospital registry of patients with acute coronary syndrome (ACS) undergoing PCI treated with prasugrel  by Omar, A. et al.
Comparative study of side branch occlusion in
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bifurcation PCI with single stent strategy eCLOSE
STUDY
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Background: Bifurcationstenting is technically challengingandside
branch compromise is a major determinant of lower procedural
success rates and adverse outcomes. We sought to compare the
incidenceof sidebranchcompromiseusingopencell designstentvs
closed cell design in patients undergoing PCI major bifurcation le-
sions using the provisional stenting approach (single stent strategy)
approach, and also the outcome of the significant side branch oc-
clusion in terms of periprocedural MI, new onset RWMA.
Methods: This is a retrospective observational study of consecu-
tive patients conducted MCH Trivandrum from Oct 2013 to April
2014. All patients who underwent coronary angiogram (CAG)& PCI
during the study period was screened, among them those planned
for bifurcation PCI with single stent strategy was included in the
study. Detailed history, physical, electrocardiographic, echocar-
diographic examination and laboratory examination results were
included. Then study population were divided into two group
based on whether they received closed or open cell design stent.
The incidence of significant side branch compromise was evalu-
ated in the each group. Post-procedural serial ECGs, cardiac en-
zymes and echocardiography were done in all patients.
Results: The mean age of study population was 56± 9years, also
mean age of the both sub group was 56± years. Males were pre-
dominant, accounting 79% of entire study population. Diabetes
mellituswaspresent in52% inopencell designand50% inclosedcell
design group. Most common indication for PCI was STEMI (44%),
followed by NSTEMI, Unstable angina (33% each). Majority had
Single vessel disease (59%), 34%had two vessel disease, three vessel
diseasewas present only in 7% of patient. Themost common site of
the bifurcation lesion is LAD ediagonal, followed by LCX-OM. Most
common type of bifurcation classification is 1.1.0(59%), followed by
1.1.1(32%). Mean size of the side branch in open cell design group
was 2.33 mm, and 2.29 in closed cell design group. There was no
significantdifference inbaseline characteristicbetween twogroups.
Out of total 118 bifurcation PCI, 9 patient had side branch
compromise ,out of which 5(55%) had periprocedural MI. Out of 9
nine branch compromise occurred, 3 had occurred in open cell
design stent group and 6 occurred in closed cell design stent
group, there is no significant difference between the groups-
probably due to small numbers.
Conclusion: Our study did not show any difference in the rate of
side branch compromise between the study groups. In accordance
withmost of the trials, our study showed side branch compromise
was commonwhen side branch size less than 2.5mm. Only 50% of
patient who had side branch compromise had periprocedural MI.
Assessment of regulatory/effector T cell balance
along with pro/anti-inflammatory cytokines level
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Background: Plaque rupture is mediated by effector CD4 T(Tcon)
cells which are normally inhibited by regulatory T cells (Treg).
Studies on Treg cell count in ST elevation myocardial infarction
(STEMI) have reported conflicting results.
Aim: To assess Treg/Tcon cell balance in STEMI patients along
with pro-inflammatory (IL 6 and TNF alpha) and anti-inflamma-
tory cytokine (IL 10).
Methods: 15 patients of STEMI along with 15 controls have been
studied till date (study is ongoing and aim is to enroll 30 patients).
Apart from peripheral blood (PB), Treg and Tcon cells were also
assessed from infarct related artery (IRA) by flowcytometry as no
study till date has assessed these cells in IRA.
Results: Mean age of patients was 47.46 ± 9.8 yrs. Mean duration
from symptom onset to sample collection was 7.5±2.2 hrs. In
cases, there was significant increase in both Treg and Tcon cells
but balance of Treg/Tcon was favourable (0.77±1.23 versus
0.22±0.19 in control (p¼ 0.50). Treg cell was significantly higher in
both PB (4.17±2.46 %,p<0.001) and IRA (4.69±4.72 %,P<0.001) versus
control (1.17±1.1 %), along with Tcon (14.40±10.29 % in
PB,16.23±9.86 % in IRA,P¼0.03) versus control (5.26±2.63 %) with
no significant difference between PB and IRA.There was also sig-
nificant increase of both anti-inflammatory cytokine in cases(IL
1030.78±50.54 pg/ml,versus 0.89±0.37 pg/ml p<0.001) along with
pro-inflammatory cytokine (IL 632.78±33.82pg/ml versus
3.05±2.59pg/ml p<0.001 and TNF alpha 39.05±57.91 pg/ml,versus
7.54±5.41 pg/ml p¼0.017) but ratio of anti-inflammatory (IL 10) to
pro-inflammatory cytokines (IL 6) increased from 0.493±0.489 in
control to 0.872±1.167 in patients (P¼NS).
Conclusion: Ratio of Treg/Tcon cell along with anti/pro-inflam-
matory cytokines increases in attempt to decrease the inflam-
matory damage in the initial stages of STEMI. So strategies to
augment Treg cell number or function may attenuate myocardial
damage till definite reperfusion therapy can be initiated.
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Background: Till recently clopidogrel has been the only available
antiplatelet drug used along with aspirin in patients of ACS. Now
two more antiplatelet drugs have become available in the form of
prasugrel (thienopyridine) and Ticagrelor (Non thienopyridine).
Prasugrel in the dose of 10 mg OD has been found to be more effi-
cacious but with increased risk of bleeding. So far the drug has not
gained widespread usage in ACS patients undergoing PCI. There
areno systematic data on theuseof Prasugrel in Indianpopulation.
Methods: This is a prospective, multicentric, hospital registry. A
minimum of 1000 patientswith ACS undergoing PCI whowould be
taking Prasugrel will be included in the study. The primary safety
endpoint of this study is major and minor bleeding while the ef-
ficacy endpoint is the composite of CV death, nonfatal MI,
nonfatal stroke up to 30 days after PCI.
Results: The requisite enrolment has been completed. Out of
which primary outcome is available for 864 patients. The average
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age of the patients was 55.95 yrs, of which 89.58 %weremales. The
average weight was 72.67 kg. The indications for PCI were 46.18 %
Unstable angina, 20.72% NSTEMI and 33.10% STEMI. 86.92% pa-
tients took a loading dose of 60 mgs whereas 13.08% patients who
had taken loading dose of clopidogrel were given only mainte-
nance dose of 10 mgs/day. A total of 26 adverse events were
noticed. Preliminary analysis revealed death of 2 patients due to
possible stent thrombosis. Three patients required revasculari-
zation (1 for stent thrombosis & 2 others for a different vessel
intervention) and 1 required rehospitalisation however for a non
cardiac cause. Major bleeding was seen in 1 patient whereas 19
patients experienced minor bleeds.
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Background: There has been no Indian data on the efficacy and
safety of prasugrel VS clopidogrel.
Aim: To compare the efficacy and safety of prasugrel with that of
clopidogrel in patients who underwent PCI.
Methods: This is a retrospective observational study. We collected
the data from patients who underwent elective/emergency PCI and
were given prasugrel and clopidogrel. The studywas between 2010-
2012. 235 patients formed the cohort. Group I consisted of 129 pa-
tients who were treated with clopidogrel and group II was of 106
patients treated with clopidogrel. Prasugrel group received loading
doseof (LD)60mg followedbymaintenancedose (MD)of 10mgonce
daily. LD and MD of clopidogrel was variable. We collected and
analysed the baseline characteristics and in hospital , 30 days, 6
months, 18 months and 24 months major adverse vascular events.
Primary end point was composite of death, ACS, stroke, emergency
revascularisation, stent thrombosis, major bleeding. Individual
secondary end points considered were admission for CCF, stent
thrombosis, instent restenosis, minor bleed, hospital stay and ACS.
Results: Mean age and sex distribution were similar in both the
groups. Dyslipidemia, hypertension, family history, two vessel
disease were higher in group II. More patients in group II had past
history of MI, prior PCI and CABG .STEMI numbers were high in
group I. Group I had significantly more primary PCI and use of GP
IIB III a blocker . In hospital complications were comparable in
both the groups. There was no significant difference between the
groups in the composite primary end points during the entire
follow up period. ACS was the only secondary endpoint that
occurred significantly in group 2 (p 0.03).
Conclusion: The efficacy and safety of prasugrel was comparable
to that of clopidogrel in our study. Occurrence of ACS was
significantly more in prasugrel group.
Acute coronary syndrome in very young adults
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Background: Acute Coronary syndrome in very young adults
(<35yrs) was considered as an uncommon entity, recently shows
rising incidence especially in India. ACS in this younger age is not,
simply a problem of sufferers but a huge emotional and
economical loss to the family.
Materials and Methods: This is a prospective analytical study
included patient <35yrs with ACS admitted in GovtRajajihospital
(Madurai Medical College) in TamilNadu during Jan2013 to June
2014. Risk factors, clinical, angiographic profile and follow up data
were recorded and analyzed.
Results: Among the total 2180 patients with ACS, 5.8 % (n¼127)
were very young adults. Youngest one was 11 yrs old with coro-
nary anomaly. Mean age was 29.7yrs (±3.7) and only 8.6% (n¼10)
were obese. Patients reached the hospital with median delay of
7hrs.Smoking (85%), male sex (93.9%) were the major conven-
tional risk factors followed by low HDL (52%). Family history of
premature coronary event seen in 12.9%, hyperhomocysteinemia,
elevated Lpa and high fibrinogen were observed in 15%, 20% &
3.5% respectively. Anteriorwall MI with LAD occlusion was the
commonest type (66.3%). Only 2 were undergone primary PCI
(1.7%), 61% (n¼71) received thrombolytic therapy. Median delay
for angiogram was 72hrs (3 days). Angiographically majority
(53.4%) had SVD, 31% had recanalised vessels. Coronary anomaly
was seen in 4 (3.4%) patients and pure ectasia in 3 (2.5%) patients.
Mean EF was 42% (±7). In hospital mortality was 3.4% and 4.5 %
(n¼5) during followup.
Conclusion: Our observation showed, obstructive CAD in 56.9% of
young ACS patients (<35yrs). This rapid progression of athero-
sclerosis in Indians is not simply due to conventional risk factors
alone but due to complex interaction of both conventional and
novel risk factors. Significant admission and therapeutic delay
implicate the need of active strategies to protect these budding
adults.
Study of factors associated with delayed
thrombolysis and its impact on mortality and
morbidity
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Background: Treatment delay in the management of STEMI /
NSTEMI inversely correlates with prognosis and survival of the
patients. This study was aimed to investigate factors associated
with delay in the thrombolytic therapy of these patients in a
municipal teaching hospital.
Methods: Data was collected prospectively of all patients who
were admitted with acute myocardial infarction from March 2014
e June 2014. Old myocardial infarction / old coronary artery
bypass graft surgery/old percutaneous transluminal coronary
angioplasty (PTCA) patients were excluded. The cardiology regis-
trar in casualty initially filled the questionnaire and sent it to the
cardiology registrar in ICCU. The cardiology registrar on duty in
ICCU completed the questionnaire at discharge. The question-
naire comprised of age, gender, weight, address, presenting
symptoms, chest pain type, onset, events between chest pain
onset and presentation to hospital, time between symptom onset
and presentation to hospital, mode of transport to hospital, risk
factors- smoking/diabetes/hypertension/dyslipidemia /family
history , previous history of angina, socioeconomic status,
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